|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 239/91 | (2006.01) |
| A61K 31/4375 | (2006.01) | ||
| A61K 31/472 | (2006.01) | ||
| A61K 31/496 | (2006.01) | ||
| A61K 31/517 | (2006.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61K 31/5377 | (2006.01) | ||
| A61P 3/06 | (2006.01) | ||
| A61P 9/00 | (2006.01) | ||
| C07D 217/24 | (2006.01) | ||
| C07D 401/04 | (2006.01) | ||
| C07D 401/12 | (2006.01) | ||
| C07D 403/10 | (2006.01) | ||
| C07D 405/04 | (2006.01) | ||
| C07D 413/06 | (2006.01) | ||
| C07D 471/04 | (2006.01) |
| (11) | Number of the document | 2118074 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07710597.1 |
| Date of filing the European patent application | 2007-02-01 | |
| (97) | Date of publication of the European application | 2009-11-18 |
| (45) | Date of publication and mention of the grant of the patent | 2014-01-22 |
| (46) | Date of publication of the claims translation | 2014-05-26 |
| (86) | Number | PCT/CA2007/000146 |
| Date | 2007-02-01 |
| (87) | Number | WO 2008/092231 |
| Date | 2008-08-07 |
| (72) |
HANSEN, Henrik, CA
|
| (73) |
RESVERLOGIX CORP.,
202, 279 Midpark Way S.E., Calgary, Alberta T2X 1M2,
CA
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Junginiai, skirti kardiovaskulinių ligų prevencijai ir gydymui |
| COMPOUNDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES |
| Payment date | Validity (years) | Amount | |
| 2025-12-22 | 20 | 347.00 EUR |